Thomas J. Montine, MD PhD - Publications

Affiliations: 
Pathology University of Washington, Seattle, Seattle, WA 

345 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, ... ... Montine TJ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain : a Journal of Neurology. PMID 31039256 DOI: 10.1093/brain/awz099  0.56
2019 Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, Blackwell TS, Montine TJ, Milne GL, McLaughlin B, Morrow JD. Correction: Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the ω -3 polyunsaturated fatty acid docosahexaenoic acid. The Journal of Biological Chemistry. 294: 6657. PMID 31003972 DOI: 10.1074/jbc.AAC119.008639  0.64
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Montine TJ, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2  0.6
2019 Stewart W, Allinson K, Al-Sarraj S, Bachmeier C, Barlow K, Belli A, Burns MP, Carson A, Crawford F, Dams-O'Connor K, Diaz-Arrastia R, Dixon CE, Edlow BL, Ferguson S, Fischl B, ... ... Montine TJ, et al. Primum non nocere: a call for balance when reporting on CTE. The Lancet. Neurology. 18: 231-233. PMID 30784550 DOI: 10.1016/S1474-4422(19)30020-1  0.56
2018 Latimer CS, Shively CA, Keene CD, Jorgensen MJ, Andrews RN, Register TC, Montine TJ, Wilson AM, Neth BJ, Mintz A, Maldjian JA, Whitlow CT, Kaplan JR, Craft S. A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30467082 DOI: 10.1016/j.jalz.2018.06.3057  0.56
2018 Gajera CR, Fernandez R, Postupna N, Montine KS, Fox EJ, Tebaykin D, Angelo M, Bendall SC, Keene CD, Montine TJ. Mass synaptometry: High-dimensional multi parametric assay for single synapses. Journal of Neuroscience Methods. PMID 30465796 DOI: 10.1016/j.jneumeth.2018.11.008  0.88
2018 Flanagan ME, Cholerton B, Latimer CS, Hemmy LS, Edland SD, Montine KS, White LR, Montine TJ. TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study. Journal of Alzheimer's Disease : Jad. PMID 30452409 DOI: 10.3233/JAD-180162  0.88
2018 Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Huentelman M, Crane PK, Resnick SM, Keene CD, ... Montine TJ, et al. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathologica. PMID 29967939 DOI: 10.1007/s00401-018-1881-4  0.64
2018 Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, ... Montine TJ, et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. Jama Neurology. PMID 29801024 DOI: 10.1001/jamaneurol.2018.0821  0.6
2018 Cholerton B, Johnson CO, Fish B, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Hu SC, Mata IF, Leverenz JB, Poston KL, Montine TJ, Zabetian CP, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & Related Disorders. PMID 29478836 DOI: 10.1016/j.parkreldis.2018.02.007  0.52
2017 Bagi Z, Brandner DD, Le P, McNeal DW, Gong X, Dou H, Fulton DJ, Beller A, Ngyuen T, Larson EB, Montine TJ, Keene CD, Back SA. Vasodilator Dysfunction and Oligodendrocyte Dysmaturation in Aging White Matter. Annals of Neurology. PMID 29283444 DOI: 10.1002/ana.25129  0.6
2017 Flanagan ME, Larson EB, Walker RL, Keene CD, Postupna N, Cholerton B, Sonnen JA, Dublin S, Crane PK, Montine TJ. Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex. Journal of Alzheimer's Disease : Jad. PMID 29226863 DOI: 10.3233/JAD-170414  0.6
2017 Miller JA, Guillozet-Bongaarts A, Gibbons LE, Postupna N, Renz A, Beller AE, Sunkin SM, Ng L, Rose SE, Smith KA, Szafer A, Barber C, Bertagnolli D, Bickley K, Brouner K, ... ... Montine TJ, et al. Neuropathological and transcriptomic characteristics of the aged brain. Elife. 6. PMID 29120328 DOI: 10.7554/eLife.31126  0.6
2017 Crane PK, Foroud T, Montine TJ, Larson EB. Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29055816 DOI: 10.1016/j.jalz.2017.09.010  0.6
2017 Latimer CS, Flanagan ME, Cimino PJ, Jayadev S, Davis M, Hoffer ZS, Montine TJ, Gonzalez-Cuyar LF, Bird TD, Keene CD. Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son. Journal of Huntington's Disease. PMID 29036832 DOI: 10.3233/JHD-170261  0.6
2017 Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, Satpathy AT, Rubin AJ, Montine KS, Wu B, Kathiria A, Cho SW, Mumbach MR, Carter AC, Kasowski M, ... ... Montine TJ, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nature Methods. PMID 28846090 DOI: 10.1038/nmeth.4396  0.88
2017 Bharadwaj R, Cimino PJ, Flanagan ME, Latimer CS, Gonzalez-Cuyar LF, Juric-Sekhar G, Montine TJ, Marshall DA, Keene CD. Application of the Condensed Protocol for the NIA-AA guidelines for the neuropathologic assessment of Alzheimer's disease in an academic clinical practice. Histopathology. PMID 28815699 DOI: 10.1111/his.13345  0.6
2017 Licking N, Murchison C, Cholerton B, Zabetian CP, Hu SC, Montine TJ, Peterson-Hiller AL, Chung KA, Edwards K, Leverenz JB, Quinn JF. Homocysteine and cognitive function in Parkinson's disease. Parkinsonism & Related Disorders. PMID 28807493 DOI: 10.1016/j.parkreldis.2017.08.005  0.52
2017 Bettcher BM, Ard MC, Reed BR, Benitez A, Simmons A, Larson EB, Sonnen JA, Montine TJ, Li G, Keene CD, Crane PK, Mungas D. Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study. Journal of Alzheimer's Disease : Jad. PMID 28731431 DOI: 10.3233/JAD-161224  0.6
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Montine TJ, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/ng.3916  0.8
2017 Li G, Shofer JB, Petrie EC, Yu CE, Wilkinson CW, Figlewicz DP, Shutes-David A, Zhang J, Montine TJ, Raskind MA, Quinn JF, Galasko DR, Peskind ER. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimer's Research & Therapy. 9: 48. PMID 28673336 DOI: 10.1186/s13195-017-0271-9  1
2017 McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, ... ... Montine TJ, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. PMID 28592453 DOI: 10.1212/WNL.0000000000004058  0.52
2017 Mata IF, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Espay AJ, Revilla FJ, ... ... Montine TJ, et al. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease. Neurobiology of Aging. PMID 28526295 DOI: 10.1016/j.neurobiolaging.2017.04.009  0.52
2017 Latimer CS, Keene CD, Flanagan ME, Hemmy LS, Lim KO, White LR, Montine KS, Montine TJ. Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies. Journal of Neuropathology and Experimental Neurology. PMID 28499012 DOI: 10.1093/jnen/nlx030  0.88
2017 Dublin S, Walker RL, Gray SL, Hubbard RA, Anderson ML, Yu O, Montine TJ, Crane PK, Sonnen JA, Larson EB. Use of Analgesics (Opioids and Nonsteroidal Anti-Inflammatory Drugs) and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort. Journal of Alzheimer's Disease : Jad. PMID 28453469 DOI: 10.3233/JAD-160374  0.6
2017 Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial. Journal of Alzheimer's Disease : Jad. PMID 28372335 DOI: 10.3233/JAD-161256  0.36
2017 Postupna N, Latimer CS, Larson EB, Sherfield E, Paladin J, Shively CA, Jorgensen MJ, Andrews RN, Kaplan JR, Crane PK, Montine KS, Craft S, Keene CD, Montine TJ. Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4. The American Journal of Pathology. PMID 28212814 DOI: 10.1016/j.ajpath.2016.12.010  0.88
2017 Jun GR, Chung J, Mez J, Barber R, Beecham GW, Bennett DA, Buxbaum JD, Byrd GS, Carrasquillo MM, Crane PK, Cruchaga C, De Jager P, Ertekin-Taner N, Evans D, Fallin MD, ... ... Montine TJ, et al. Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28183528 DOI: 10.1016/j.jalz.2016.12.012  0.6
2017 Flanagan ME, Marshall DA, Shofer JB, Montine KS, Nelson PT, Montine TJ, Keene CD. Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease. Journal of Neuropathology and Experimental Neurology. PMID 28062571 DOI: 10.1093/jnen/nlw104  0.88
2017 Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, ... ... Montine TJ, et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. The Lancet. Neurology. 16: 55-65. PMID 27979356 DOI: 10.1016/S1474-4422(16)30291-5  0.56
2016 Cholerton B, Baker LD, Montine TJ, Craft S. Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach. Diabetes Spectrum : a Publication of the American Diabetes Association. 29: 210-219. PMID 27899872 DOI: 10.2337/ds16-0041  0.36
2016 Crane PK, Walker RL, Sonnen J, Gibbons LE, Melrose R, Hassenstab J, Keene CD, Postupna N, Montine TJ, Larson EB. Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes. Neurobiology of Aging. 48: 72-82. PMID 27644076 DOI: 10.1016/j.neurobiolaging.2016.07.021  0.6
2016 Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, ... ... Montine TJ, et al. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. Jama Neurology. PMID 27571329 DOI: 10.1001/jamaneurol.2016.2245  0.52
2016 Liachko NF, Saxton AD, McMillan PJ, Strovas TJ, Currey HN, Taylor LM, Wheeler JM, Oblak AL, Ghetti B, Montine TJ, Keene CD, Raskind MA, Bird TD, Kraemer BC. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation. Acta Neuropathologica. PMID 27473149 DOI: 10.1007/s00401-016-1600-y  1
2016 Crane PK, Gibbons LE, Dams-O'Connor K, Trittschuh E, Leverenz JB, Keene CD, Sonnen J, Montine TJ, Bennett DA, Leurgans S, Schneider JA, Larson EB. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. Jama Neurology. PMID 27400367 DOI: 10.1001/jamaneurol.2016.1948  0.6
2016 Takeda S, Commins C, DeVos SL, Nobuhara CK, Wegmann S, Roe AD, Costantino I, Fan Z, Nicholls SB, Sherman AE, Trisini Lipsanopoulos AT, Scherzer CR, Carlson GA, Pitstick R, Peskind ER, ... ... Montine TJ, et al. Seed-competent HMW tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients. Annals of Neurology. PMID 27351289 DOI: 10.1002/ana.24716  0.64
2016 Hoekstra JG, Hipp MJ, Montine TJ, Kennedy SR. Mitochondrial DNA Mutations Increase in Early Stage Alzheimer's Disease and are Inconsistent with Oxidative Damage. Annals of Neurology. PMID 27315116 DOI: 10.1002/ana.24709  0.88
2016 Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, ... ... Montine TJ, et al. CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27234211 DOI: 10.1016/j.jalz.2016.04.003  1
2016 Davis MY, Trinh K, Thomas RE, Yu S, Germanos AA, Whitley BN, Sardi SP, Montine TJ, Pallanck LJ. Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration. Plos Genetics. 12: e1005944. PMID 27019408 DOI: 10.1371/journal.pgen.1005944  1
2016 White LR, Edland SD, Hemmy LS, Montine KS, Zarow C, Sonnen JA, Uyehara-Lock JH, Gelber RP, Ross GW, Petrovitch H, Masaki KH, Lim KO, Launer LJ, Montine TJ. Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies. Neurology. PMID 26888993 DOI: 10.1212/WNL.0000000000002480  1
2015 Cholerton B, Larson EB, Quinn JF, Zabetian CP, Mata IF, Keene CD, Flanagan M, Crane PK, Grabowski TJ, Montine KS, Montine TJ. Precision Medicine: Clarity for the Complexity of Dementia. The American Journal of Pathology. PMID 26724389 DOI: 10.1016/j.ajpath.2015.12.001  1
2015 Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, ... ... Montine TJ, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/s00401-015-1509-x  1
2015 Crane PK, Gibbons LE, McCurry SM, McCormick W, Bowen JD, Sonnen J, Keene CD, Grabowski T, Montine TJ, Larson EB. Importance of home study visit capacity in dementia studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26602628 DOI: 10.1016/j.jalz.2015.10.007  0.6
2015 Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau. Journal of Alzheimer's Disease : Jad. 47: 883-7. PMID 26401768 DOI: 10.3233/JAD-150420  1
2015 Shang J, Zrazhevskiy P, Postupna N, Keene CD, Montine TJ, Gao X. Multiplexed In-cell Immunoassay for Same-sample Protein Expression Profiling. Scientific Reports. 5: 13651. PMID 26328896 DOI: 10.1038/srep13651  0.56
2015 Montine TJ, Monsell SE, Beach TG, Bigio EH, Bu Y, Cairns NJ, Frosch M, Henriksen J, Kofler J, Kukull WA, Lee EB, Nelson PT, Schantz AM, Schneider JA, Sonnen JA, et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26327235 DOI: 10.1016/j.jalz.2015.07.492  0.6
2015 Flanagan M, Larson EB, Latimer CS, Cholerton B, Crane PK, Montine KS, White LR, Dirk Keene C, Montine TJ. Clinical-pathologic correlations in vascular cognitive impairment and dementia. Biochimica Et Biophysica Acta. PMID 26319420 DOI: 10.1016/j.bbadis.2015.08.019  1
2015 Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. Jama Neurology. PMID 26302353 DOI: 10.1001/jamaneurol.2015.1721  1
2015 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, ... ... Montine TJ, et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26296077 DOI: 10.1002/mds.26359  1
2015 Madhyastha TM, Askren MK, Zhang J, Leverenz JB, Montine TJ, Grabowski TJ. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease. Brain : a Journal of Neurology. 138: 2672-86. PMID 26173859 DOI: 10.1093/brain/awv189  1
2015 Yang Y, Keene CD, Peskind ER, Galasko DR, Hu SC, Cudaback E, Wilson AM, Li G, Yu CE, Montine KS, Zhang J, Baird GS, Hyman BT, Montine TJ. Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. Journal of Neuropathology and Experimental Neurology. 74: 672-87. PMID 26083568 DOI: 10.1097/NEN.0000000000000207  1
2015 Garrett Morgan R, Gibbs JT, Melief EJ, Postupna NO, Sherfield EE, Wilson A, Dirk Keene C, Montine TJ, Palmiter RD, Darvas M. Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment. Experimental Neurology. 271: 205-214. PMID 26079646 DOI: 10.1016/j.expneurol.2015.06.013  1
2015 Kelly VE, Johnson CO, McGough EL, Shumway-Cook A, Horak FB, Chung KA, Espay AJ, Revilla FJ, Devoto J, Wood-Siverio C, Factor SA, Cholerton B, Edwards KL, Peterson AL, Quinn JF, ... Montine TJ, et al. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease. Parkinsonism & Related Disorders. 21: 692-7. PMID 25943529 DOI: 10.1016/j.parkreldis.2015.04.002  1
2015 Montine TJ, Montine KS. Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases. The Journal of Experimental Medicine. 212: 601-5. PMID 25941321 DOI: 10.1084/jem.20150656  0.88
2015 Melief EJ, Cudaback E, Jorstad NL, Sherfield E, Postupna N, Wilson A, Darvas M, Montine KS, Keene CD, Montine TJ. Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease. Journal of Neuroscience Research. 93: 1413-22. PMID 25824456 DOI: 10.1002/jnr.23592  1
2015 Bekris LM, Tsuang DW, Peskind ER, Yu CE, Montine TJ, Zhang J, Zabetian CP, Leverenz JB. Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 936-44. PMID 25808939 DOI: 10.1002/mds.26172  1
2015 Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, ... Montine TJ, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/s00401-015-1407-2  1
2015 Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, ... ... Montine TJ, et al. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology. 84: 972-80. PMID 25663231 DOI: 10.1212/WNL.0000000000001332  1
2015 Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, ... ... Montine TJ, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/mds.26161  1
2015 Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 709-19. PMID 25613100 DOI: 10.3233/JAD-143099  1
2015 Li X, Montine KS, Keene CD, Montine TJ. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1754-62. PMID 25593125 DOI: 10.1096/fj.14-262683  1
2015 Postupna N, Keene CD, Crane PK, Gonzalez-Cuyar LF, Sonnen JA, Hewitt J, Rice S, Howard K, Montine KS, Larson EB, Montine TJ. Cerebral cortical Aβ42 and PHF-Ï„ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE. Journal of Neuropathology and Experimental Neurology. 74: 100-9. PMID 25575135 DOI: 10.1097/NEN.0000000000000153  1
2015 Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Montine TJ, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/jamaneurol.2014.2157  0.36
2015 Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 710-717. PMID 25510382 DOI: 10.1016/j.jalz.2014.10.008  1
2015 Li X, Melief E, Postupna N, Montine KS, Keene CD, Montine TJ. Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis. The American Journal of Pathology. 185: 230-9. PMID 25452117 DOI: 10.1016/j.ajpath.2014.09.016  0.88
2015 Cudaback E, Yang Y, Montine TJ, Keene CD. APOE genotype-dependent modulation of astrocyte chemokine CCL3 production. Glia. 63: 51-65. PMID 25092803 DOI: 10.1002/glia.22732  1
2014 Liachko NF, McMillan PJ, Strovas TJ, Loomis E, Greenup L, Murrell JR, Ghetti B, Raskind MA, Montine TJ, Bird TD, Leverenz JB, Kraemer BC. The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43. Plos Genetics. 10: e1004803. PMID 25473830 DOI: 10.1371/journal.pgen.1004803  1
2014 Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, ... ... Montine TJ, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica. 128: 755-66. PMID 25348064 DOI: 10.1007/s00401-014-1349-0  1
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Montine TJ, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/jamaneurol.2014.1491  1
2014 Yang Y, Aloi MS, Cudaback E, Josephsen SR, Rice SJ, Jorstad NL, Keene CD, Montine TJ. Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 1224-36. PMID 25199051 DOI: 10.1038/labinvest.2014.113  1
2014 Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Kamboh MI, ... ... Montine TJ, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. Plos Genetics. 10: e1004606. PMID 25188341 DOI: 10.1371/journal.pgen.1004606  1
2014 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, ... ... Montine TJ, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. Jama Neurology. 71: 1405-12. PMID 25178429 DOI: 10.1001/jamaneurol.2014.1455  1
2014 Sieber BA, Landis S, Koroshetz W, Bateman R, Siderowf A, Galpern WR, Dunlop J, Finkbeiner S, Sutherland M, Wang H, Lee VM, Orr HT, Gwinn K, Ludwig K, Taylor A, ... ... Montine TJ, et al. Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference. Annals of Neurology. 76: 469-72. PMID 25164235 DOI: 10.1002/ana.24261  1
2014 Hardikar S, Onstad L, Song X, Wilson AM, Montine TJ, Kratz M, Anderson GL, Blount PL, Reid BJ, White E, Vaughan TL. Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2393-403. PMID 25106775 DOI: 10.1158/1055-9965.EPI-14-0384  1
2014 Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML, Knopman DS, Kuzmichev AN, Manly JJ, Marder KS, Miller BL, Phelps CH, Seeley WW, et al. Recommendations of the Alzheimer's disease-related dementias conference. Neurology. 83: 851-60. PMID 25080517 DOI: 10.1212/WNL.0000000000000733  1
2014 Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, ... Montine TJ, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1258-64. PMID 25073717 DOI: 10.1002/mds.25924  1
2014 Postupna NO, Keene CD, Latimer C, Sherfield EE, Van Gelder RD, Ojemann JG, Montine TJ, Darvas M. Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 1161-72. PMID 25068655 DOI: 10.1038/labinvest.2014.103  1
2014 Peskind ER, Li G, Shofer JB, Millard SP, Leverenz JB, Yu CE, Raskind MA, Quinn JF, Galasko DR, Montine TJ. Influence of lifestyle modifications on age-related free radical injury to brain. Jama Neurology. 71: 1150-4. PMID 25048271 DOI: 10.1001/jamaneurol.2014.1428  1
2014 Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, ... ... Montine TJ, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathologica. 127: 825-43. PMID 24770881 DOI: 10.1007/s00401-014-1282-2  1
2014 Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, Galasko DR, Montine TJ. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. Jama Neurology. 71: 742-51. PMID 24756381 DOI: 10.1001/jamaneurol.2014.445  1
2014 Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL. Evaluation of mild cognitive impairment subtypes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 756-64. PMID 24710804 DOI: 10.1002/mds.25875  1
2014 Nuytemans K, Inchausti V, Beecham GW, Wang L, Dickson DW, Trojanowski JQ, Lee VM, Mash DC, Frosch MP, Foroud TM, Honig LS, Montine TJ, Dawson TM, Martin ER, Scott WK, et al. Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 827-30. PMID 24573903 DOI: 10.1002/mds.25838  1
2014 Hales CM, Dammer EB, Diner I, Yi H, Seyfried NT, Gearing M, Glass JD, Montine TJ, Levey AI, Lah JJ. Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 24: 344-51. PMID 24571648 DOI: 10.1111/bpa.12133  1
2014 Cudaback E, Jorstad NL, Yang Y, Montine TJ, Keene CD. Therapeutic implications of the prostaglandin pathway in Alzheimer's disease. Biochemical Pharmacology. 88: 565-72. PMID 24434190 DOI: 10.1016/j.bcp.2013.12.014  0.6
2014 Johnston JM, Hu WT, Fardo DW, Greco SJ, Perry G, Montine TJ, Trojanowski JQ, Shaw LM, Ashford JW, Tezapsidis N. Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential. Current Alzheimer Research. 11: 165-74. PMID 24359504 DOI: 10.2174/1567205010666131212114156  1
2014 Dublin S, Anderson ML, Heckbert SR, Hubbard RA, Sonnen JA, Crane PK, Montine TJ, Larson EB. Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 69: 609-15. PMID 24077599 DOI: 10.1093/gerona/glt141  1
2014 Mukherjee S, Kim S, Ramanan VK, Gibbons LE, Nho K, Glymour MM, Ertekin-Taner N, Montine TJ, Saykin AJ, Crane PK. Gene-based GWAS and biological pathway analysis of the resilience of executive functioning. Brain Imaging and Behavior. 8: 110-8. PMID 24072271 DOI: 10.1007/s11682-013-9259-7  1
2014 Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, et al. The future of blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 115-31. PMID 23850333 DOI: 10.1016/j.jalz.2013.01.013  1
2013 Herskowitz JH, Feng Y, Mattheyses AL, Hales CM, Higginbotham LA, Duong DM, Montine TJ, Troncoso JC, Thambisetty M, Seyfried NT, Levey AI, Lah JJ. Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19086-98. PMID 24305806 DOI: 10.1523/JNEUROSCI.2508-13.2013  1
2013 Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, Smith AV, Chouraki V, ... ... Montine TJ, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics. 45: 1452-8. PMID 24162737 DOI: 10.1038/ng.2802  0.36
2013 Hales CM, Rees H, Seyfried NT, Dammer EB, Duong DM, Gearing M, Montine TJ, Troncoso JC, Thambisetty M, Levey AI, Lah JJ, Wingo TS. Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes. Journal of Neuropathology and Experimental Neurology. 72: 1009-15. PMID 24128675 DOI: 10.1097/01.jnen.0000435847.59828.db  1
2013 Bai B, Hales CM, Chen PC, Gozal Y, Dammer EB, Fritz JJ, Wang X, Xia Q, Duong DM, Street C, Cantero G, Cheng D, Jones DR, Wu Z, Li Y, ... ... Montine TJ, et al. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 16562-7. PMID 24023061 DOI: 10.1073/pnas.1310249110  1
2013 Cholerton BA, Zabetian CP, Quinn JF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Edwards KL, Montine TJ, Leverenz JB. Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics. Journal of Parkinson's Disease. 3: 205-14. PMID 23938350 DOI: 10.3233/JPD-130189  1
2013 Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB. Glucose levels and risk of dementia. The New England Journal of Medicine. 369: 540-8. PMID 23924004 DOI: 10.1056/NEJMoa1215740  1
2013 Yang Y, Cudaback E, Jorstad NL, Hemingway JF, Hagan CE, Melief EJ, Li X, Yoo T, Khademi SB, Montine KS, Montine TJ, Keene CD. APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease. The American Journal of Pathology. 183: 905-17. PMID 23831297 DOI: 10.1016/j.ajpath.2013.05.009  1
2013 Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, Leverenz JB. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 18: 455-66. PMID 23822153 DOI: 10.3109/1354750X.2013.814073  1
2013 Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. Jama Neurology. 70: 972-80. PMID 23779114 DOI: 10.1001/jamaneurol.2013.396  1
2013 Cholerton B, Larson EB, Baker LD, Craft S, Crane PK, Millard SP, Sonnen JA, Montine TJ. Neuropathologic correlates of cognition in a population-based sample. Journal of Alzheimer's Disease : Jad. 36: 699-709. PMID 23666176 DOI: 10.3233/JAD-130281  1
2013 Yang Y, Jorstad NL, Shiao C, Cherne MK, Khademi SB, Montine KS, Montine TJ, Keene CD. Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation. Experimental and Molecular Pathology. 95: 7-17. PMID 23567123 DOI: 10.1016/j.yexmp.2013.03.010  1
2013 Preston M, Gong X, Su W, Matsumoto SG, Banine F, Winkler C, Foster S, Xing R, Struve J, Dean J, Baggenstoss B, Weigel PH, Montine TJ, Back SA, Sherman LS. Digestion products of the PH20 hyaluronidase inhibit remyelination. Annals of Neurology. 73: 266-80. PMID 23463525 DOI: 10.1002/ana.23788  1
2013 Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, B Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Annals of Neurology. 74: 119-27. PMID 23447138 DOI: 10.1002/ana.23872  1
2013 Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, ... ... Montine TJ, et al. APOE ε4 increases risk for dementia in pure synucleinopathies. Jama Neurology. 70: 223-8. PMID 23407718 DOI: 10.1001/jamaneurol.2013.600  1
2013 Cimino PJ, Yang Y, Li X, Hemingway JF, Cherne MK, Khademi SB, Fukui Y, Montine KS, Montine TJ, Keene CD. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease. Experimental and Molecular Pathology. 94: 366-71. PMID 23318649 DOI: 10.1016/j.yexmp.2013.01.002  1
2013 Watson GS, Cholerton BA, Gross RG, Weintraub D, Zabetian CP, Trojanowski JQ, Montine TJ, Siderowf A, Leverenz JB. Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 609-14. PMID 23164549 DOI: 10.1016/j.jalz.2012.07.006  1
2013 Li X, Rose SE, Montine KS, Keene CD, Montine TJ. Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitro. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 87-93. PMID 22718277 DOI: 10.1007/s11481-012-9380-1  1
2013 Montine KS, Montine TJ. Anatomic and clinical pathology of cognitive impairment and dementia. Journal of Alzheimer's Disease : Jad. 33: S181-4. PMID 22699849 DOI: 10.3233/JAD-2012-129032  0.88
2012 Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/srep00954  1
2012 Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, ... ... Montine TJ, et al. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimer's Research & Therapy. 4: 43. PMID 23107780 DOI: 10.1186/alzrt146  1
2012 Chan WF, Gurnot C, Montine TJ, Sonnen JA, Guthrie KA, Nelson JL. Male microchimerism in the human female brain. Plos One. 7: e45592. PMID 23049819 DOI: 10.1371/journal.pone.0045592  1
2012 Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ. Neuropathologic substrates of Parkinson disease dementia. Annals of Neurology. 72: 587-98. PMID 23037886 DOI: 10.1002/ana.23659  1
2012 Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, ... ... Montine TJ, et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 79: 1944-50. PMID 23035075 DOI: 10.1212/WNL.0b013e3182735e9a  1
2012 Shi J, Wang Q, Johansson JU, Liang X, Woodling NS, Priyam P, Loui TM, Merchant M, Breyer RM, Montine TJ, Andreasson K. Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. Annals of Neurology. 72: 788-98. PMID 22915243 DOI: 10.1002/ana.23677  0.52
2012 Cudaback E, Li X, Yang Y, Yoo T, Montine KS, Craft S, Montine TJ, Keene CD. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. Journal of Neuroinflammation. 9: 192. PMID 22883744 DOI: 10.1186/1742-2094-9-192  0.88
2012 Mukherjee S, Kim S, Gibbons LE, Nho K, Risacher SL, Glymour MM, Habeck C, Lee GJ, Mormino E, Ertekin-Taner N, Montine TJ, Decarli C, Saykin AJ, Crane PK. Genetic architecture of resilience of executive functioning. Brain Imaging and Behavior. 6: 621-33. PMID 22711244 DOI: 10.1007/s11682-012-9184-1  1
2012 Schellenberg GD, Montine TJ. The genetics and neuropathology of Alzheimer's disease. Acta Neuropathologica. 124: 305-23. PMID 22618995 DOI: 10.1007/s00401-012-0996-2  1
2012 Bekris LM, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Montine TJ, Peskind ER, Yu CE. ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiology of Aging. 33: 2229.e1-2229.e9. PMID 22572541 DOI: 10.1016/j.neurobiolaging.2012.03.013  1
2012 Li X, Cudaback E, Breyer RM, Montine KS, Keene CD, Montine TJ. Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 3075-83. PMID 22499581 DOI: 10.1096/fj.11-200279  0.88
2012 Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, ... ... Montine TJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/NEN.0b013e31825018f7  1
2012 Montine TJ, Sonnen JA, Montine KS, Crane PK, Larson EB. Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics. Current Alzheimer Research. 9: 718-23. PMID 22471861  1
2012 Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Archives of Neurology. 69: 836-41. PMID 22431837 DOI: 10.1001/archneurol.2012.85  1
2012 Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, ... ... Montine TJ, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 1-13. PMID 22265587 DOI: 10.1016/j.jalz.2011.10.007  1
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/s00259-011-2045-0  1
2012 Baird GS, Nelson SK, Keeney TR, Stewart A, Williams S, Kraemer S, Peskind ER, Montine TJ. Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array. The American Journal of Pathology. 180: 446-56. PMID 22122984 DOI: 10.1016/j.ajpath.2011.10.024  1
2012 Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathologica. 123: 1-11. PMID 22101365 DOI: 10.1007/s00401-011-0910-3  1
2012 Postupna N, Rose SE, Bird TD, Gonzalez-Cuyar LF, Sonnen JA, Larson EB, Keene CD, Montine TJ. Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults. Brain Pathology (Zurich, Switzerland). 22: 472-84. PMID 21999410 DOI: 10.1111/j.1750-3639.2011.00542.x  1
2012 Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 28: 137-46. PMID 21971406 DOI: 10.3233/JAD-2011-111076  1
2012 Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of Neurology. 69: 29-38. PMID 21911655 DOI: 10.1001/archneurol.2011.233  1
2011 Beutler LR, Eldred KC, Quintana A, Keene CD, Rose SE, Postupna N, Montine TJ, Palmiter RD. Severely impaired learning and altered neuronal morphology in mice lacking NMDA receptors in medium spiny neurons. Plos One. 6: e28168. PMID 22132236 DOI: 10.1371/journal.pone.0028168  1
2011 Keene CD, Cudaback E, Li X, Montine KS, Montine TJ. Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease. Current Opinion in Neurobiology. 21: 920-8. PMID 21907569 DOI: 10.1016/j.conb.2011.08.002  0.88
2011 Back SA, Kroenke CD, Sherman LS, Lawrence G, Gong X, Taber EN, Sonnen JA, Larson EB, Montine TJ. White matter lesions defined by diffusion tensor imaging in older adults. Annals of Neurology. 70: 465-76. PMID 21905080 DOI: 10.1002/ana.22484  1
2011 Sonnen JA, Santa Cruz K, Hemmy LS, Woltjer R, Leverenz JB, Montine KS, Jack CR, Kaye J, Lim K, Larson EB, White L, Montine TJ. Ecology of the aging human brain. Archives of Neurology. 68: 1049-56. PMID 21825242 DOI: 10.1001/archneurol.2011.157  1
2011 Milatovic D, Montine TJ, Aschner M. Measurement of isoprostanes as markers of oxidative stress. Methods in Molecular Biology (Clifton, N.J.). 758: 195-204. PMID 21815067 DOI: 10.1007/978-1-61779-170-3_13  0.4
2011 Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN, et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 402-11. PMID 21784351 DOI: 10.1016/j.jalz.2010.12.014  1
2011 Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, ... ... Montine TJ, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 386-395.e6. PMID 21784349 DOI: 10.1016/j.jalz.2011.05.2243  1
2011 Gonzalez-Cuyar LF, Sonnen JA, Montine KS, Keene CD, Montine TJ. Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment. Current Neurology and Neuroscience Reports. 11: 455-63. PMID 21725901 DOI: 10.1007/s11910-011-0212-0  0.88
2011 Hoekstra JG, Montine KS, Zhang J, Montine TJ. Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease. Alzheimer's Research & Therapy. 3: 21. PMID 21722346 DOI: 10.1186/alzrt83  1
2011 Davies SS, Bodine C, Matafonova E, Pantazides BG, Bernoud-Hubac N, Harrison FE, Olson SJ, Montine TJ, Amarnath V, Roberts LJ. Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice. Journal of Alzheimer's Disease : Jad. 27: 49-59. PMID 21709376 DOI: 10.3233/JAD-2011-102118  0.64
2011 Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Archives of Neurology. 68: 743-52. PMID 21670398 DOI: 10.1001/archneurol.2011.125  1
2011 Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 280-92. PMID 21514248 DOI: 10.1016/j.jalz.2011.03.003  1
2011 Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, ... ... Montine TJ, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics. 43: 436-41. PMID 21460841 DOI: 10.1038/ng.801  0.36
2011 Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, et al. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. The American Journal of Pathology. 178: 1509-16. PMID 21435440 DOI: 10.1016/j.ajpath.2011.01.006  1
2011 Jayadev S, Nochlin D, Poorkaj P, Steinbart EJ, Mastrianni JA, Montine TJ, Ghetti B, Schellenberg GD, Bird TD, Leverenz JB. Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Annals of Neurology. 69: 712-20. PMID 21416485 DOI: 10.1002/ana.22264  0.52
2011 Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Annals of Neurology. 69: 570-80. PMID 21400565 DOI: 10.1002/ana.22311  1
2011 Cudaback E, Li X, Montine KS, Montine TJ, Keene CD. Apolipoprotein E isoform-dependent microglia migration. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 2082-91. PMID 21385991 DOI: 10.1096/fj.10-176891  0.88
2011 Milatovic D, Montine TJ, Aschner M. Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity. Neurotoxicology. 32: 312-9. PMID 21376752 DOI: 10.1016/j.neuro.2011.02.004  0.4
2011 Li X, Cudaback E, Keene CD, Breyer RM, Montine TJ. Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activation. Glia. 59: 569-76. PMID 21319223 DOI: 10.1002/glia.21125  1
2011 Leverenz JB, Watson GS, Shofer J, Zabetian CP, Zhang J, Montine TJ. Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease. Parkinsonism & Related Disorders. 17: 61-4. PMID 21044858 DOI: 10.1016/j.parkreldis.2010.10.003  1
2011 Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers. Neuromolecular Medicine. 13: 37-43. PMID 20632131 DOI: 10.1007/s12017-010-8126-6  1
2010 Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, Craft S, Kahn CR. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metabolism. 12: 567-79. PMID 21109190 DOI: 10.1016/j.cmet.2010.11.006  1
2010 Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2682-5. PMID 20818673 DOI: 10.1002/mds.23287  1
2010 Sonnen JA, Larson EB, Walker RL, Haneuse S, Crane PK, Gray SL, Breitner JC, Montine TJ. Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology. 75: 1203-10. PMID 20811000 DOI: 10.1212/WNL.0b013e3181f52db1  1
2010 Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, ... ... Montine TJ, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology. 67: 1473-84. PMID 20697030 DOI: 10.1001/archneurol.2010.201  1
2010 Haque JA, McMahan RS, Campbell JS, Shimizu-Albergine M, Wilson AM, Botta D, Bammler TK, Beyer RP, Montine TJ, Yeh MM, Kavanagh TJ, Fausto N. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 90: 1704-17. PMID 20548286 DOI: 10.1038/labinvest.2010.112  1
2010 Woltjer RL, Duerson K, Fullmer JM, Mookherjee P, Ryan AM, Montine TJ, Kaye JA, Quinn JF, Silbert L, Erten-Lyons D, Leverenz JB, Bird TD, Pow DV, Tanaka K, Watson GS, et al. Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 69: 667-76. PMID 20535038 DOI: 10.1097/NEN.0b013e3181e24adb  1
2010 Keene CD, Chang RC, Lopez-Yglesias AH, Shalloway BR, Sokal I, Li X, Reed PJ, Keene LM, Montine KS, Breyer RM, Rockhill JK, Montine TJ. Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow. The American Journal of Pathology. 177: 346-54. PMID 20522650 DOI: 10.2353/ajpath.2010.090840  1
2010 Sonnen JA, Postupna N, Larson EB, Crane PK, Rose SE, Montine KS, Leverenz JB, Montine TJ. Pathologic correlates of dementia in individuals with Lewy body disease. Brain Pathology (Zurich, Switzerland). 20: 654-9. PMID 20522091 DOI: 10.1111/j.1750-3639.2009.00371.x  1
2010 Shi J, Johansson J, Woodling NS, Wang Q, Montine TJ, Andreasson K. The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. Journal of Immunology (Baltimore, Md. : 1950). 184: 7207-18. PMID 20483760 DOI: 10.4049/jimmunol.0903487  0.52
2010 Snyder LR, Hoggard JC, Montine TJ, Synovec RE. Development and application of a comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method for the analysis of L-beta-methylamino-alanine in human tissue. Journal of Chromatography. A. 1217: 4639-47. PMID 20483417 DOI: 10.1016/j.chroma.2010.04.065  1
2010 Milatovic D, Montine TJ, Zaja-Milatovic S, Madison JL, Bowman AB, Aschner M. Morphometric analysis in neurodegenerative disorders. Current Protocols in Toxicology / Editorial Board, Mahin D. Maines (Editor-in-Chief) ... [Et Al.]. Unit 12.16. PMID 20401325 DOI: 10.1002/0471140856.tx1216s43  1
2010 Galasko D, Montine TJ. Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomarkers in Medicine. 4: 27-36. PMID 20383271 DOI: 10.2217/bmm.09.89  1
2010 Rostomily RC, Born DE, Beyer RP, Jin J, Alvord EC, Mikheev AM, Matthews RT, Pan C, Khorasani L, Sonnen JA, Montine TJ, Shi M, Zhang J. Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion. Journal of Proteome Research. 9: 2610-8. PMID 20337498 DOI: 10.1021/pr100054v  1
2010 Montine TJ, Sonnen JA, Milne G, Baker LD, Breitner JC. Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. Plos One. 5: e9340. PMID 20174466 DOI: 10.1371/journal.pone.0009340  1
2010 Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain : a Journal of Neurology. 133: 713-26. PMID 20157014 DOI: 10.1093/brain/awq008  1
2010 Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Archives of Neurology. 67: 161-70. PMID 20142524 DOI: 10.1001/archneurol.2009.328  1
2010 Sonnen JA, Montine KS, Quinn JF, Breitner JC, Montine TJ. Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia. Journal of Alzheimer's Disease : Jad. 19: 301-9. PMID 20061646 DOI: 10.3233/JAD-2010-1236  1
2010 Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu CE. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 409-17. PMID 19554612 DOI: 10.1002/ajmg.b.30993  1
2010 Tsuang D, Larson EB, Li G, Shofer JB, Montine KS, Thompson ML, Sonnen JA, Crane PK, Leverenz JB, Montine TJ. Association between lifetime cigarette smoking and lewy body accumulation. Brain Pathology (Zurich, Switzerland). 20: 412-8. PMID 19531100 DOI: 10.1111/j.1750-3639.2009.00296.x  1
2010 Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrometry Reviews. 29: 79-125. PMID 19358229 DOI: 10.1002/mas.20221  1
2009 Montine TJ, Larson EB. Late-life dementias: does this unyielding global challenge require a broader view? Jama. 302: 2593-4. PMID 20009062 DOI: 10.1001/jama.2009.1863  1
2009 Longstreth WT, Sonnen JA, Koepsell TD, Kukull WA, Larson EB, Montine TJ. Associations between microinfarcts and other macroscopic vascular findings on neuropathologic examination in 2 databases. Alzheimer Disease and Associated Disorders. 23: 291-4. PMID 19812473 DOI: 10.1097/WAD.0b013e318199fc7a  1
2009 Wang LY, Larson EB, Sonnen JA, Shofer JB, McCormick W, Bowen JD, Montine TJ, Li G. Blood pressure and brain injury in older adults: findings from a community-based autopsy study. Journal of the American Geriatrics Society. 57: 1975-81. PMID 19793158 DOI: 10.1111/j.1532-5415.2009.02493.x  1
2009 Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, Montine TJ. Cognitive impairment and dementia in patients with Parkinson disease. Current Topics in Medicinal Chemistry. 9: 903-12. PMID 19754405 DOI: 10.2174/156802609789378218  1
2009 Cimino PJ, Sokal I, Leverenz J, Fukui Y, Montine TJ. DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain. The American Journal of Pathology. 175: 1622-30. PMID 19729484 DOI: 10.2353/ajpath.2009.090443  1
2009 Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue. Toxicology and Applied Pharmacology. 240: 180-8. PMID 19716838 DOI: 10.1016/j.taap.2009.06.025  1
2009 Martin Mdel P, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-Demasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. Archives of Neurology. 66: 1016-20. PMID 19667224 DOI: 10.1001/archneurol.2009.157  1
2009 Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK, Craft S, Montine TJ. Neuropathology in the adult changes in thought study: a review. Journal of Alzheimer's Disease : Jad. 18: 703-11. PMID 19661627 DOI: 10.3233/JAD-2009-1180  1
2009 Nayyar T, Bubser M, Ferguson MC, Neely MD, Shawn Goodwin J, Montine TJ, Deutch AY, Ansah TA. Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation. The European Journal of Neuroscience. 30: 207-16. PMID 19659923 DOI: 10.1111/j.1460-9568.2009.06806.x  1
2009 Shi M, Bradner J, Bammler TK, Eaton DL, Zhang J, Ye Z, Wilson AM, Montine TJ, Pan C, Zhang J. Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. The American Journal of Pathology. 175: 54-65. PMID 19498008 DOI: 10.2353/ajpath.2009.081019  1
2009 Savonenko A, Munoz P, Melnikova T, Wang Q, Liang X, Breyer RM, Montine TJ, Kirkwood A, Andreasson K. Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor. Experimental Neurology. 217: 63-73. PMID 19416671 DOI: 10.1016/j.expneurol.2009.01.016  1
2009 Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE, Bekris LM, Raskind MA, Galasko DR, Montine TJ. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. Plos One. 4: e5424. PMID 19412541 DOI: 10.1371/journal.pone.0005424  1
2009 Keene CD, Chang R, Stephen C, Nivison M, Nutt SE, Look A, Breyer RM, Horner PJ, Hevner R, Montine TJ. Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2. The American Journal of Pathology. 174: 2300-9. PMID 19389932 DOI: 10.2353/ajpath.2009.081153  1
2009 Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. Lack of cerebral bmaa in human cerebral cortex. Neurology. 72: 1360-1. PMID 19365059 DOI: 10.1212/WNL.0b013e3181a0fed1  1
2009 Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner JC, Montine TJ. Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Annals of Neurology. 65: 226-9. PMID 19259965 DOI: 10.1002/ana.21508  1
2009 Shie FS, Nivison M, Hsu PC, Montine TJ. Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma. Current Medicinal Chemistry. 16: 643-51. PMID 19199928 DOI: 10.2174/092986709787458399  1
2009 Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S. Different patterns of cerebral injury in dementia with or without diabetes. Archives of Neurology. 66: 315-22. PMID 19139294 DOI: 10.1001/archneurol.2008.579  1
2009 Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, Hevner RF, Born DE, Bird TD, Montine TJ. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathologica. 117: 329-38. PMID 19057918 DOI: 10.1007/s00401-008-0465-0  1
2009 Woltjer RL, Sonnen JA, Sokal I, Rung LG, Yang W, Kjerulf JD, Klingert D, Johnson C, Rhew I, Tsuang D, Crane PK, Larson EB, Montine TJ. Quantitation and mapping of cerebral detergent-insoluble proteins in the elderly. Brain Pathology (Zurich, Switzerland). 19: 365-74. PMID 18652590 DOI: 10.1111/j.1750-3639.2008.00190.x  1
2009 Duerson K, Woltjer RL, Mookherjee P, Leverenz JB, Montine TJ, Bird TD, Pow DV, Rauen T, Cook DG. Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients. Brain Pathology (Zurich, Switzerland). 19: 267-78. PMID 18624794 DOI: 10.1111/j.1750-3639.2008.00186.x  1
2008 Caudle WM, Pan S, Shi M, Quinn T, Hoekstra J, Beyer RP, Montine TJ, Zhang J. Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease. Proteomics. Clinical Applications. 2: 1484-97. PMID 21136796 DOI: 10.1002/prca.200800043  1
2008 Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ, Andreasson K. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Annals of Neurology. 64: 304-14. PMID 18825663 DOI: 10.1002/ana.21437  0.52
2008 Zhang J, Keene CD, Pan C, Montine KS, Montine TJ. Proteomics of human neurodegenerative diseases. Journal of Neuropathology and Experimental Neurology. 67: 923-32. PMID 18800015 DOI: 10.1097/NEN.0b013e318187a832  1
2008 Cole B, Montine TJ, True L, Sonnen J. 70-year-old man with enlarged pineal gland. Brain Pathology (Zurich, Switzerland). 18: 602-4. PMID 18782174 DOI: 10.1111/j.1750-3639.2008.00210.x  1
2008 Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ. Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Current Medicinal Chemistry. 15: 1863-9. PMID 18691044 DOI: 10.2174/092986708785132915  1
2008 Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JC, Montine TJ. Biomarkers for cognitive impairment and dementia in elderly people. The Lancet. Neurology. 7: 704-14. PMID 18635019 DOI: 10.1016/S1474-4422(08)70162-5  1
2008 Zaja-Milatovic S, Gupta RC, Aschner M, Montine TJ, Milatovic D. Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum. Neurotoxicology. 29: 621-7. PMID 18556069 DOI: 10.1016/j.neuro.2008.04.009  0.4
2008 Brat DJ, Parisi JE, Kleinschmidt-DeMasters BK, Yachnis AT, Montine TJ, Boyer PJ, Powell SZ, Prayson RA, McLendon RE. Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Archives of Pathology & Laboratory Medicine. 132: 993-1007. PMID 18517285 DOI: 10.1043/1543-2165(2008)132[993:SNUARO]2.0.CO;2  1
2008 Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, Blackwell TS, Montine TJ, Milne GL, McLaughlin B, Morrow JD. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. The Journal of Biological Chemistry. 283: 19927-35. PMID 18490445 DOI: 10.1074/jbc.M803625200  1
2008 Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radical Biology & Medicine. 45: 219-30. PMID 18482592 DOI: 10.1016/j.freeradbiomed.2008.04.022  1
2008 Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen-Plotkin AS, Martinez-Lage M, Steinbart E, McCluskey L, Grossman M, Neumann M, Wu IL, ... ... Montine TJ, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. The Lancet. Neurology. 7: 409-16. PMID 18396105 DOI: 10.1016/S1474-4422(08)70071-1  1
2008 Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. American Journal of Clinical Pathology. 129: 526-9. PMID 18343778 DOI: 10.1309/W01Y0B808EMEH12L  1
2008 Baird GS, Montine TJ. Multiplex immunoassay analysis of cytokines in idiopathic inflammatory myopathy. Archives of Pathology & Laboratory Medicine. 132: 232-8. PMID 18251582 DOI: 10.1043/1543-2165(2008)132[232:MIAOCI]2.0.CO;2  1
2008 VanRollins M, Woltjer RL, Yin H, Morrow JD, Montine TJ. F2-dihomo-isoprostanes arise from free radical attack on adrenic acid. Journal of Lipid Research. 49: 995-1005. PMID 18250368 DOI: 10.1194/jlr.M700503-JLR200  1
2008 Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathology (Zurich, Switzerland). 18: 220-4. PMID 18241240 DOI: 10.1111/j.1750-3639.2007.00117.x  1
2008 Wilmot B, McWeeney SK, Nixon RR, Montine TJ, Laut J, Harrington CA, Kaye JA, Kramer PL. Translational gene mapping of cognitive decline. Neurobiology of Aging. 29: 524-41. PMID 17174450 DOI: 10.1016/j.neurobiolaging.2006.11.008  1
2007 Bruno RS, Leonard SW, Atkinson J, Montine TJ, Ramakrishnan R, Bray TM, Traber MG. Response to Harri Hemilä, Ph.D., M.D. - "Conclusions about intervention effects should not be based on surrogate end points. Free Radical Biology & Medicine. 42: 579-580. PMID 18274602 DOI: 10.1016/j.freeradbiomed.2006.11.034  1
2007 Picklo MJ, Montine TJ. Mitochondrial effects of lipid-derived neurotoxins. Journal of Alzheimer's Disease : Jad. 12: 185-93. PMID 17917163  0.64
2007 Montine TJ, Quinn J, Kaye J, Morrow JD. F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. Journal of Molecular Neuroscience : Mn. 33: 114-9. PMID 17901555  0.64
2007 Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Annals of Neurology. 62: 406-13. PMID 17879383 DOI: 10.1002/ana.21208  1
2007 Li G, Larson EB, Sonnen JA, Shofer JB, Petrie EC, Schantz A, Peskind ER, Raskind MA, Breitner JC, Montine TJ. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology. 69: 878-85. PMID 17724290 DOI: 10.1212/01.wnl.0000277657.95487.1c  0.64
2007 Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, Kaye JA, Raskind MA, Zhang J, Peskind ER, Montine TJ. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology. 69: 631-9. PMID 17698783 DOI: 10.1212/01.wnl.0000267428.62582.aa  1
2007 Sonnen JA, Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ. Biomarkers for Alzheimer's disease. Expert Review of Neurotherapeutics. 7: 1021-8. PMID 17678497 DOI: 10.1586/14737175.7.8.1021  1
2007 Yang W, Woltjer RL, Sokal I, Pan C, Wang Y, Brodey M, Peskind ER, Leverenz JB, Zhang J, Perl DP, Galasko DR, Montine TJ. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. The American Journal of Pathology. 171: 993-1002. PMID 17675576 DOI: 10.2353/ajpath.2007.070015  1
2007 Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, ... ... Montine TJ, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica. 114: 221-9. PMID 17653732 DOI: 10.1007/s00401-007-0261-2  1
2007 Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, Bird TD, Montine TJ. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology. 68: 2093-8. PMID 17562830 DOI: 10.1212/01.wnl.0000264504.14301.f5  1
2007 Leverenz JB, Yu CE, Montine TJ, Steinbart E, Bekris LM, Zabetian C, Kwong LK, Lee VM, Schellenberg GD, Bird TD. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain : a Journal of Neurology. 130: 1360-74. PMID 17439980 DOI: 10.1093/brain/awm069  1
2007 Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J. Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathology (Zurich, Switzerland). 17: 139-45. PMID 17388944 DOI: 10.1111/j.1750-3639.2007.00048.x  1
2007 Zhang J, Montine TJ. Proteomic discovery of CSF biomarkers for Alzheimer's disease. Annals of Neurology. 61: 497; author reply 49. PMID 17358005 DOI: 10.1002/ana.21109  1
2007 Pan S, Zhu D, Quinn JF, Peskind ER, Montine TJ, Lin B, Goodlett DR, Taylor G, Eng J, Zhang J. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics. 7: 469-73. PMID 17211832 DOI: 10.1002/pmic.200600756  1
2007 Jin J, Shie FS, Liu J, Wang Y, Davis J, Schantz AM, Montine KS, Montine TJ, Zhang J. Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein. Journal of Neuroinflammation. 4: 2. PMID 17204153 DOI: 10.1186/1742-2094-4-2  1
2007 Woltjer RL, McMahan W, Milatovic D, Kjerulf JD, Shie FS, Rung LG, Montine KS, Montine TJ. Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment. Neurobiology of Disease. 25: 427-37. PMID 17141508 DOI: 10.1016/j.nbd.2006.10.003  1
2007 Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiology of Aging. 28: 213-25. PMID 16448723 DOI: 10.1016/j.neurobiolaging.2005.12.014  1
2006 Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. Journal of Alzheimer's Disease : Jad. 10: 399-406. PMID 17183151  1
2006 Dodson SE, Gearing M, Lippa CF, Montine TJ, Levey AI, Lah JJ. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 65: 866-72. PMID 16957580 DOI: 10.1097/01.jnen.0000228205.19915.20  1
2006 Maezawa I, Zaja-Milatovic S, Milatovic D, Stephen C, Sokal I, Maeda N, Montine TJ, Montine KS. Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity. Journal of Neuroinflammation. 3: 21. PMID 16934151 DOI: 10.1186/1742-2094-3-21  1
2006 Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, ... ... Montine TJ, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. Journal of Alzheimer's Disease : Jad. 9: 293-348. PMID 16914840  1
2006 Tsuang DW, Riekse RG, Purganan KM, David AC, Montine TJ, Schellenberg GD, Steinbart EJ, Petrie EC, Bird TD, Leverenz JB. Lewy body pathology in late-onset familial Alzheimer's disease: a clinicopathological case series. Journal of Alzheimer's Disease : Jad. 9: 235-42. PMID 16914833  1
2006 Boutte AM, Woltjer RL, Zimmerman LJ, Stamer SL, Montine KS, Manno MV, Cimino PJ, Liebler DC, Montine TJ. Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1473-83. PMID 16816122 DOI: 10.1096/fj.06-5920com  1
2006 Montine TJ, Woltjer RL, Pan C, Montine KS, Zhang J. Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 336-43. PMID 16815217 DOI: 10.1016/j.nurx.2006.05.002  1
2006 Xu J, Chen J, Peskind ER, Jin J, Eng J, Pan C, Montine TJ, Goodlett DR, Zhang J. Characterization of proteome of human cerebrospinal fluid. International Review of Neurobiology. 73: 29-98. PMID 16737901 DOI: 10.1016/S0074-7742(06)73002-1  1
2006 Zaja-Milatovic S, Keene CD, Montine KS, Leverenz JB, Tsuang D, Montine TJ. Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology. 66: 1591-3. PMID 16717229 DOI: 10.1212/01.wnl.0000216137.09685.c1  0.88
2006 Maezawa I, Maeda N, Montine TJ, Montine KS. Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice. Journal of Neuroinflammation. 3: 10. PMID 16603079 DOI: 10.1186/1742-2094-3-10  1
2006 Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, Raskind MA, Schellenberg GD, Bird TD, Tsuang D. Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Archives of Neurology. 63: 370-6. PMID 16533963 DOI: 10.1001/archneur.63.3.370  0.64
2006 Maezawa I, Nivison M, Montine KS, Maeda N, Montine TJ. Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 797-9. PMID 16481366 DOI: 10.1096/fj.05-5423fje  1
2006 Bruno RS, Leonard SW, Atkinson J, Montine TJ, Ramakrishnan R, Bray TM, Traber MG. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radical Biology & Medicine. 40: 689-97. PMID 16458200 DOI: 10.1016/j.freeradbiomed.2005.10.051  1
2006 Boutaud O, Montine TJ, Chang L, Klein WL, Oates JA. PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42. Journal of Neurochemistry. 96: 917-23. PMID 16412101 DOI: 10.1111/j.1471-4159.2005.03586.x  1
2005 Zhang J, Goodlett DR, Montine TJ. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. Journal of Alzheimer's Disease : Jad. 8: 377-86. PMID 16556969  1
2005 Montine TJ, Quinn JF, Montine KS, Kaye JA, Breitner JC. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 8: 359-67. PMID 16556967  0.88
2005 Liang X, Wang Q, Hand T, Wu L, Breyer RM, Montine TJ, Andreasson K. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10180-7. PMID 16267225 DOI: 10.1523/JNEUROSCI.3591-05.2005  0.52
2005 Milatovic D, VanRollins M, Li K, Montine KS, Montine TJ. Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 827: 88-93. PMID 16260380 DOI: 10.1016/j.jchromb.2005.03.037  0.88
2005 Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Archives of Neurology. 62: 1539-44. PMID 16216936 DOI: 10.1001/archneur.62.10.noc50112  1
2005 Montine TJ, Li K, Perl DP, Galasko D. Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology. 65: 768-9. PMID 16157919 DOI: 10.1212/01.wnl.0000174523.62022.52  0.36
2005 Boutté AM, Neely MD, Bird TD, Montine KS, Montine TJ. Diminished taxol/GTP-stimulated tubulin polymerization in diseased region of brain from patients with late-onset or inherited Alzheimer's disease or frontotemporal dementia with parkinsonism linked to chromosome-17 but not individuals with mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 8: 1-6. PMID 16155344  1
2005 Woltjer RL, Cimino PJ, Boutté AM, Schantz AM, Montine KS, Larson EB, Bird T, Quinn JF, Zhang J, Montine TJ. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1923-5. PMID 16129700 DOI: 10.1096/fj.05-4263fje  1
2005 Zagol-Ikapitte I, Masterson TS, Amarnath V, Montine TJ, Andreasson KI, Boutaud O, Oates JA. Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity. Journal of Neurochemistry. 94: 1140-5. PMID 15992375 DOI: 10.1111/j.1471-4159.2005.03264.x  0.64
2005 Back SA, Luo NL, Mallinson RA, O'Malley JP, Wallen LD, Frei B, Morrow JD, Petito CK, Roberts CT, Murdoch GH, Montine TJ. Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Annals of Neurology. 58: 108-20. PMID 15984031 DOI: 10.1002/ana.20530  0.64
2005 Shie FS, Montine KS, Breyer RM, Montine TJ. Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity. Glia. 52: 70-7. PMID 15920732 DOI: 10.1002/glia.20220  1
2005 Shie FS, Montine KS, Breyer RM, Montine TJ. Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons. Brain Pathology (Zurich, Switzerland). 15: 134-8. PMID 15912885  1
2005 Woltjer RL, Nghiem W, Maezawa I, Milatovic D, Vaisar T, Montine KS, Montine TJ. Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. Journal of Neurochemistry. 93: 1047-56. PMID 15857408 DOI: 10.1111/j.1471-4159.2005.03109.x  1
2005 Montine TJ, Morrow JD. Fatty acid oxidation in the pathogenesis of Alzheimer's disease. The American Journal of Pathology. 166: 1283-9. PMID 15855630 DOI: 10.1016/S0002-9440(10)62347-4  0.64
2005 Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. Journal of Alzheimer's Disease : Jad. 7: 125-33; discussion 1. PMID 15851850  1
2005 Shie FS, Breyer RM, Montine TJ. Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity. The American Journal of Pathology. 166: 1163-72. PMID 15793296  1
2005 Neely MD, Boutte A, Milatovic D, Montine TJ. Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Research. 1037: 90-8. PMID 15777756 DOI: 10.1016/j.brainres.2004.12.027  1
2005 Wang Q, Woltjer RL, Cimino PJ, Pan C, Montine KS, Zhang J, Montine TJ. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 869-71. PMID 15746184 DOI: 10.1096/fj.04-3210fje  1
2005 Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, Samii A, Deutch AY, Montine TJ. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology. 64: 545-7. PMID 15699393 DOI: 10.1212/01.WNL.0000150591.33787.A4  1
2005 Milatovic D, Gupta RC, Dekundy A, Montine TJ, Dettbarn WD. Carbofuran-induced oxidative stress in slow and fast skeletal muscles: prevention by memantine and atropine. Toxicology. 208: 13-24. PMID 15664429 DOI: 10.1016/j.tox.2004.11.004  0.4
2005 Montine TJ, Montine KS, McMahan W, Markesbery WR, Quinn JF, Morrow JD. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxidants & Redox Signaling. 7: 269-75. PMID 15650414 DOI: 10.1089/ars.2005.7.269  1
2005 Bruno RS, Ramakrishnan R, Montine TJ, Bray TM, Traber MG. {alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. The American Journal of Clinical Nutrition. 81: 95-103. PMID 15640466  1
2005 Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiology of Aging. 26: 207-27. PMID 15582749 DOI: 10.1016/j.neurobiolaging.2004.03.012  1
2004 Maezawa I, Jin LW, Woltjer RL, Maeda N, Martin GM, Montine TJ, Montine KS. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. Journal of Neurochemistry. 91: 1312-21. PMID 15584908 DOI: 10.1111/j.1471-4159.2004.02818.x  1
2004 Garland EM, Vnencak-Jones CL, Biaggioni I, Davis TL, Montine TJ, Robertson D. Fragile X gene premutation in multiple system atrophy. Journal of the Neurological Sciences. 227: 115-8. PMID 15546601 DOI: 10.1016/j.jns.2004.08.013  1
2004 Milatovic D, Zaja-Milatovic S, Montine KS, Shie FS, Montine TJ. Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo. Journal of Neuroinflammation. 1: 20. PMID 15498098 DOI: 10.1186/1742-2094-1-20  1
2004 Zhou Y, Shie FS, Piccardo P, Montine TJ, Zhang J. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience. 128: 281-91. PMID 15350641 DOI: 10.1016/j.neuroscience.2004.06.048  1
2004 Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, et al. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Journal of Neurochemistry. 90: 1011-8. PMID 15287908 DOI: 10.1111/j.1471-4159.2004.02532.x  1
2004 Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J. Analysis of alpha-synuclein-associated proteins by quantitative proteomics. The Journal of Biological Chemistry. 279: 39155-64. PMID 15234983 DOI: 10.1074/jbc.M405456200  1
2004 Murphy TC, Poppe C, Porter JE, Montine TJ, Picklo MJ. 4-Hydroxy-trans-2-nonenoic acid is a gamma-hydroxybutyrate receptor ligand in the cerebral cortex and hippocampus. Journal of Neurochemistry. 89: 1462-70. PMID 15189349 DOI: 10.1111/j.1471-4159.2004.02442.x  1
2004 Garden GA, Guo W, Jayadev S, Tun C, Balcaitis S, Choi J, Montine TJ, Möller T, Morrison RS. HIV associated neurodegeneration requires p53 in neurons and microglia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1141-3. PMID 15155568 DOI: 10.1096/fj.04-1676fje  1
2004 Shie FS, Neely MD, Maezawa I, Wu H, Olson SJ, Jürgens G, Montine KS, Montine TJ. Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. The American Journal of Pathology. 164: 1173-81. PMID 15039206 DOI: 10.1016/S0002-9440(10)63205-1  1
2004 Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJ, Morrow JD, Montine TJ. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chemistry and Physics of Lipids. 128: 117-24. PMID 15037157 DOI: 10.1016/j.chemphyslip.2003.10.010  1
2004 Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 6: 93-7. PMID 15004331  0.88
2004 Musiek ES, Cha JK, Yin H, Zackert WE, Terry ES, Porter NA, Montine TJ, Morrow JD. Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 799: 95-102. PMID 14659440 DOI: 10.1016/j.jchromb.2003.10.036  1
2003 Woltjer RL, Maezawa I, Ou JJ, Montine KS, Montine TJ. Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity. Journal of Alzheimer's Disease : Jad. 5: 467-76. PMID 14757937  1
2003 Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ, Montine TJ. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. Journal of Neurochemistry. 87: 1518-26. PMID 14713307  1
2003 Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, Hurtig HI, Lee VM, Trojanowski JQ. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathologica. 106: 243-50. PMID 12811584 DOI: 10.1007/s00401-003-0726-x  1
2003 Hill KE, Montine TJ, Motley AK, Li X, May JM, Burk RF. Combined deficiency of vitamins E and C causes paralysis and death in guinea pigs. The American Journal of Clinical Nutrition. 77: 1484-8. PMID 12791628  0.56
2003 Pulliam JF, Jennings CD, Kryscio RJ, Davis DG, Wilson D, Montine TJ, Schmitt FA, Markesbery WR. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 48-53. PMID 12707938 DOI: 10.1002/ajmg.b.10069  1
2003 Bassett CN, Montine TJ. Lipoproteins and lipid peroxidation in Alzheimer's disease. The Journal of Nutrition, Health & Aging. 7: 24-9. PMID 12679837  1
2003 Sidell KR, Montine KS, Picklo MJ, Olsen SJ, Amarnath V, Montine TJ. Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. Journal of Neuropathology and Experimental Neurology. 62: 146-53. PMID 12578224  1
2003 Montine TJ, Montine KS, Reich EE, Terry ES, Porter NA, Morrow JD. Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes. Biochemical Pharmacology. 65: 611-7. PMID 12566089 DOI: 10.1016/S0006-2952(02)01607-6  1
2003 Zhang J, Fitsanakis VA, Gu G, Jing D, Ao M, Amarnath V, Montine TJ. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. Journal of Neurochemistry. 84: 336-46. PMID 12558996 DOI: 10.1046/j.1471-4159.2003.01525.x  1
2002 Montine KS, Sidell KR, Zhang J, Montine TJ. Dopamine thioethers: formation in brain and neurotoxicity. Neurotoxicity Research. 4: 663-669. PMID 12709304 DOI: 10.1080/1029842021000045435  1
2002 Reich EE, Montine TJ, Morrow JD. Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Advances in Experimental Medicine and Biology. 507: 519-24. PMID 12664634  1
2002 Fitsanakis VA, Amarnath V, Moore JT, Montine KS, Zhang J, Montine TJ. Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides. Free Radical Biology & Medicine. 33: 1714-23. PMID 12488139 DOI: 10.1016/S0891-5849(02)01169-3  1
2002 Picklo MJ, Montine TJ, Amarnath V, Neely MD. Carbonyl toxicology and Alzheimer's disease. Toxicology and Applied Pharmacology. 184: 187-97. PMID 12460747  0.64
2002 Neely MD, Montine TJ. CSF lipoproteins and Alzheimer's disease. The Journal of Nutrition, Health & Aging. 6: 383-91. PMID 12459889  0.48
2002 Montine TJ, Milatovic D, Gupta RC, Valyi-Nagy T, Morrow JD, Breyer RM. Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. Journal of Neurochemistry. 83: 463-70. PMID 12423256  0.64
2002 Boutaud O, Ou JJ, Chaurand P, Caprioli RM, Montine TJ, Oates JA. Prostaglandin H2 (PGH2) accelerates formation of amyloid beta1-42 oligomers. Journal of Neurochemistry. 82: 1003-6. PMID 12358806 DOI: 10.1046/j.1471-4159.2002.01064.x  1
2002 Bassett CN, Swift LL, Montine KS, Markesbery WR, Montine TJ. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration. Journal of Alzheimer's Disease : Jad. 4: 19-30. PMID 12214015  1
2002 Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ, Kaye JA, Morrow JD. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Annals of Neurology. 52: 175-9. PMID 12210787 DOI: 10.1002/ana.10272  0.64
2002 Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biology & Medicine. 33: 620-6. PMID 12208348 DOI: 10.1016/S0891-5849(02)00807-9  1
2002 Milatovic D, Zhang Y, Olson SJ, Montine KS, Roberts LJ, Morrow JD, Montine TJ, Dermody TS, Valyi-Nagy T. Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes. Journal of Neurovirology. 8: 295-305. PMID 12161814 DOI: 10.1080/13550280290100743  1
2002 Fam SS, Murphey LJ, Terry ES, Zackert WE, Chen Y, Gao L, Pandalai S, Milne GL, Roberts LJ, Porter NA, Montine TJ, Morrow JD. Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. The Journal of Biological Chemistry. 277: 36076-84. PMID 12133837 DOI: 10.1074/jbc.M205638200  1
2002 Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. Journal of Neuropathology and Experimental Neurology. 61: 634-9. PMID 12125742  1
2002 Ou JJ, Zhang Y, Montine TJ. In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases. Experimental Neurology. 175: 363-9. PMID 12061866 DOI: 10.1006/exnr.2002.7923  1
2002 Zhang J, Montine TJ, Smith MA, Siedlak SL, Gu G, Robertson D, Perry G. The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism & Related Disorders. 8: 165-70. PMID 12039426 DOI: 10.1016/S1353-8020(01)00041-4  1
2002 Davies SS, Amarnath V, Montine KS, Bernoud-Hubac N, Boutaud O, Montine TJ, Roberts LJ. Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 715-7. PMID 11978738 DOI: 10.1096/fj.01-0696fje  0.88
2002 Montine KS, Montine TJ, Morrow JD, Frei B, Milatovic D, Eckenstein F, Quinn JF. Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment. Brain Research. 930: 75-82. PMID 11879798 DOI: 10.1016/S0006-8993(01)03409-6  1
2002 Neely MD, Amarnath V, Weitlauf C, Montine TJ. Synthesis and cellular effects of an intracellularly activated analogue of 4-hydroxynonenal. Chemical Research in Toxicology. 15: 40-7. PMID 11800596 DOI: 10.1021/tx010115w  1
2001 Sidell KR, Amamath V, Montine TJ. Dopamine thioethers in neurodegeneration. Current Topics in Medicinal Chemistry. 1: 519-27. PMID 11895128  1
2001 Reich EE, Markesbery WR, Roberts LJ, Swift LL, Morrow JD, Montine TJ. Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Advances in Experimental Medicine and Biology. 500: 253-6. PMID 11764949  1
2001 Morales CR, Terry ES, Zackert WE, Montine TJ, Morrow JD. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay. Clinica Chimica Acta; International Journal of Clinical Chemistry. 314: 93-9. PMID 11718683 DOI: 10.1016/S0009-8981(01)00637-4  1
2001 Sidell KR, Olson SJ, Ou JJ, Zhang Y, Amarnath V, Montine TJ. Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. Journal of Neurochemistry. 79: 510-21. PMID 11701754 DOI: 10.1046/j.1471-4159.2001.00586.x  1
2001 Picklo MJ, Olson SJ, Hayes JD, Markesbery WR, Montine TJ. Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease. Brain Research. 916: 229-38. PMID 11597610 DOI: 10.1016/S0006-8993(01)02897-9  1
2001 Reich EE, Montine KS, Gross MD, Roberts LJ, Swift LL, Morrow JD, Montine TJ. Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5993-9. PMID 11487622  1
2001 Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 60: 686-95. PMID 11444797  1
2001 Xie C, Lovell MA, Xiong S, Kindy MS, Guo J, Xie J, Amaranth V, Montine TJ, Markesbery WR. Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radical Biology & Medicine. 31: 73-81. PMID 11425492 DOI: 10.1016/S0891-5849(01)00553-6  1
2001 Bernoud-Hubac N, Davies SS, Boutaud O, Montine TJ, Roberts LJ. Formation of highly reactive gamma-ketoaldehydes (neuroketals) as products of the neuroprostane pathway. The Journal of Biological Chemistry. 276: 30964-70. PMID 11413140 DOI: 10.1074/jbc.M103768200  0.44
2001 Picklo MJ, Montine TJ. Acrolein inhibits respiration in isolated brain mitochondria. Biochimica Et Biophysica Acta. 1535: 145-52. PMID 11342003  0.64
2001 Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, Quinn JF. Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls. Archives of Pathology & Laboratory Medicine. 125: 510-2. PMID 11260625 DOI: 10.1043/0003-9985(2001)125<0510:CFATAF>2.0.CO;2  0.88
2001 Reich EE, Markesbery WR, Roberts LJ, Swift LL, Morrow JD, Montine TJ. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. The American Journal of Pathology. 158: 293-7. PMID 11141503 DOI: 10.1016/S0002-9440(10)63968-5  1
2000 Montine TJ, Amarnath V, Picklo MJ, Sidell KR, Zhang J, Graham DG. Dopamine mercapturate can augment dopaminergic neurodegeneration. Drug Metabolism Reviews. 32: 363-76. PMID 11139134 DOI: 10.1081/DMR-100102339  1
2000 Neely MD, Swift LL, Montine TJ. Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules. Lipids. 35: 1249-57. PMID 11132184  0.48
2000 Valyi-Nagy T, Olson SJ, Valyi-Nagy K, Montine TJ, Dermody TS. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology. 278: 309-21. PMID 11118355 DOI: 10.1006/viro.2000.0678  1
2000 Montine TJ, Shinobu L, Montine KS, Roberts LJ, Kowall NW, Beal MF, Morrow JD. No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls. Annals of Neurology. 48: 950. PMID 11117557 DOI: 10.1002/1531-8249(200012)48:6<950::AID-ANA23>3.0.CO;2-F  1
2000 Neely MD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, Montine KS, Amaranth V, Montine TJ. Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radical Biology & Medicine. 29: 1028-36. PMID 11084291 DOI: 10.1016/S0891-5849(00)00411-1  1
2000 Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VM, Trojanowski JQ. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. Journal of Neuropathology and Experimental Neurology. 59: 830-41. PMID 11005264  1
2000 Bassett CN, Montine KS, Neely MD, Swift LL, Montine TJ. Cerebrospinal fluid lipoproteins in Alzheimer's disease. Microscopy Research and Technique. 50: 282-6. PMID 10936881 DOI: 10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T  1
2000 Ho L, Luterman JD, Aisen PS, Pasinetti GM, Montine TJ, Morrow JD. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 55: 323. PMID 10908926  1
2000 Zhang J, Graham DG, Montine TJ, Ho YS. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. Journal of Neuropathology and Experimental Neurology. 59: 53-61. PMID 10744035  1
2000 Reich EE, Zackert WE, Brame CJ, Chen Y, Roberts LJ, Hachey DL, Montine TJ, Morrow JD. Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry. 39: 2376-83. PMID 10694406 DOI: 10.1021/bi992000l  1
2000 Zhang J, Kravtsov V, Amarnath V, Picklo MJ, Graham DG, Montine TJ. Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. Journal of Neurochemistry. 74: 970-8. PMID 10693927  1
1999 Morrow JD, Tapper AR, Zackert WE, Yang J, Sanchez SC, Montine TJ, Roberts LJ. Formation of novel isoprostane-like compounds from docosahexaenoic acid. Advances in Experimental Medicine and Biology. 469: 343-7. PMID 10667351  0.64
1999 Bassett CN, Neely MD, Sidell KR, Markesbery WR, Swift LL, Montine TJ. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids. 34: 1273-80. PMID 10652986  1
1999 Valyi-Nagy T, Sidell KR, Marnett LJ, Roberts LJ, Dermody TS, Morrow JD, Montine TJ. Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis. Journal of Neuropathology and Experimental Neurology. 58: 1269-75. PMID 10604752  1
1999 Picklo MJ, Zhang J, Nguyen VQ, Graham DG, Montine TJ. High-pressure liquid chromatography quantitation of cytochrome c using 393 nm detection. Analytical Biochemistry. 276: 166-70. PMID 10603239 DOI: 10.1006/abio.1999.4349  1
1999 Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ, Morrow JD. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 53: 1495-8. PMID 10534257  1
1999 Montine TJ, Markesbery WR, Zackert W, Sanchez SC, Roberts LJ, Morrow JD. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. The American Journal of Pathology. 155: 863-8. PMID 10487843 DOI: 10.1016/S0002-9440(10)65185-1  1
1999 Picklo MJ, Amarnath V, Graham DG, Montine TJ. Endogenous catechol thioethers may be pro-oxidant or antioxidant. Free Radical Biology & Medicine. 27: 271-7. PMID 10468198  0.64
1999 Montine TJ, Montine KS, Olson SJ, Graham DG, Roberts LJ, Morrow JD, Linton MF, Fazio S, Swift LL. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice. Experimental Neurology. 158: 234-41. PMID 10448437 DOI: 10.1006/exnr.1999.7067  1
1999 Neely MD, Sidell KR, Graham DG, Montine TJ. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. Journal of Neurochemistry. 72: 2323-33. PMID 10349841 DOI: 10.1046/j.1471-4159.1999.0722323.x  1
1999 Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, Montine TJ. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. The American Journal of Pathology. 154: 1423-9. PMID 10329595 DOI: 10.1016/S0002-9440(10)65396-5  1
1999 Montine TJ, Beal MF, Robertson D, Cudkowicz ME, Biaggioni I, O'Donnell H, Zackert WE, Roberts LJ, Morrow JD. Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology. 52: 1104-5. PMID 10102447  0.64
1999 Picklo MJ, Amarnath V, McIntyre JO, Graham DG, Montine TJ. 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. Journal of Neurochemistry. 72: 1617-24. PMID 10098869  0.64
1999 Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Increased CSF F2-isoprostane concentration in probable AD. Neurology. 52: 562-5. PMID 10025788  0.64
1998 Montine KS, Bassett CN, Ou JJ, Markesbery WR, Swift LL, Montine TJ. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins. Journal of Lipid Research. 39: 2443-51. PMID 9831633  1
1998 Montine TJ, Markesbery WR, Morrow JD, Roberts LJ. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Annals of Neurology. 44: 410-3. PMID 9749613 DOI: 10.1002/ana.410440322  0.64
1998 Zhang J, Price JO, Graham DG, Montine TJ. Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochemical and Biophysical Research Communications. 248: 812-6. PMID 9704010 DOI: 10.1006/bbrc.1998.9044  1
1998 Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. Journal of Neuropathology and Experimental Neurology. 57: 415-25. PMID 9596412  1
1998 Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. The Journal of Biological Chemistry. 273: 13605-12. PMID 9593698 DOI: 10.1074/jbc.273.22.13605  1
1998 Amarnath V, Valentine WM, Montine TJ, Patterson WH, Amarnath K, Bassett CN, Graham DG. Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy. Chemical Research in Toxicology. 11: 317-28. PMID 9548802 DOI: 10.1021/tx970176n  0.52
1997 Montine TJ, Montine KS, Swift LL. Central nervous system lipoproteins in Alzheimer's disease. The American Journal of Pathology. 151: 1571-5. PMID 9403708  0.88
1997 Montine TJ, Picklo MJ, Amarnath V, Whetsell WO, Graham DG. Neurotoxicity of endogenous cysteinylcatechols. Experimental Neurology. 148: 26-33. PMID 9398447 DOI: 10.1006/exnr.1997.6662  1
1997 Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. Journal of Neuropathology and Experimental Neurology. 56: 866-71. PMID 9258256  0.88
1997 Montine KS, Olson SJ, Amarnath V, Whetsell WO, Graham DG, Montine TJ. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. The American Journal of Pathology. 150: 437-43. PMID 9033259  1
1996 Montine TJ, Huang DY, Valentine WM, Amarnath V, Saunders A, Weisgraber KH, Graham DG, Strittmatter WJ. Crosslinking of apolipoprotein E by products of lipid peroxidation. Journal of Neuropathology and Experimental Neurology. 55: 202-10. PMID 8786379  1
1996 Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. The American Journal of Pathology. 148: 89-93. PMID 8546230  1
Show low-probability matches.